Surgery Partners is poised to go private in a roughly $5.7 billion transaction led by HealthSpan Partners, an affiliate of Bon Secours, according to reports from The Wall Street Journal and other outlets. The deal would remove the Brentwood, Tennessee-based outpatient surgery operator from the public markets and cap a period in which healthcare services assets have drawn renewed interest from strategic buyers seeking scale, stable cash flow and exposure to non-acute care delivery.
The acquisition, if completed, would represent a major endorsement of Surgery Partners' business model at a time when investors have been re-rating healthcare providers based on their ability to deliver procedures outside expensive hospital settings. Surgery Partners operates a network of ambulatory surgery centers and related services, a segment that has benefited from payer pressure to shift care to lower-cost venues and from patients increasingly favoring convenience and shorter recovery times.
Premium Signals Confidence
Shares of Surgery Partners surged on the reports, with traders quickly marking up the stock toward what would be its strongest session in more than six years. That reaction suggests the market sees the proposed price as a meaningful premium to where the stock had been trading before the deal news emerged. It also reflects a broader pattern in public equities: when strategic buyers move on healthcare operators with predictable revenue streams, public investors often rush to capture the spread between market value and deal value.
For Bon Secours and HealthSpan, the transaction would likely provide a direct path to expand influence in outpatient care without the quarterly scrutiny of public markets. Take-private deals can give operators more flexibility to invest in technology, staffing and facility expansion while avoiding the volatility that often comes with public ownership in a sector sensitive to reimbursement changes, labor costs and procedure volume trends.
Outpatient Care Attracts Buyers
The reported transaction also underscores how attractive ambulatory surgery centers have become to both nonprofit health systems and private capital. These assets can generate strong margins relative to other healthcare businesses because they focus on scheduled procedures, often with lower overhead than inpatient hospitals. In a market where health systems are trying to control costs and broaden access, ownership of surgery centers can be strategically important.
Bon Secours, part of the larger Catholic health system network, would be using an affiliate structure to deepen its footprint in a segment that aligns with the industry's migration toward outpatient treatment. That shift has been underway for years, but it has accelerated as insurers, employers and patients push for lower-cost alternatives to hospital-based care. A successful acquisition would also give HealthSpan a larger platform to compete for physician partnerships and procedure volume.
Market Watches Next Steps
The deal is not yet complete, and the usual closing risks remain. Large healthcare transactions can face regulatory review, financing considerations and shareholder approval requirements, particularly when a public company is being taken private at a substantial valuation. Investors will be watching for formal confirmation of terms, any competing bids and the structure of the financing package.
Even so, the reported agreement fits a wider trend in global markets in which strategic acquirers are selectively targeting listed companies whose valuations have lagged their perceived long-term worth. For Surgery Partners, the move would end a public-market run that has at times been shaped by concerns over labor inflation, procedure mix and reimbursement pressure, but also by the company's ability to scale in a fragmented industry.
If finalized, the transaction would be one of the most significant healthcare services deals of the year and a reminder that outpatient care remains a prized asset class. It would also reinforce the view that, in a market still searching for growth, buyers are willing to pay up for businesses with recurring demand, operational resilience and clear strategic fit.